Presidio Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2014-06-16. The offering totals $22.5M, of which $21.8M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 33 people.
| Name | Role | Location |
|---|---|---|
| Omar Haffar | Director | San Francisco, CA |
| Scott Lessing | Director | San Francisco, CA |
| H. Daniel Perez | Director | San Francisco, CA |
| Leo Redmond | Director | San Francisco, CA |
| Robert Williamson | Director | Miami Shores, FL |
| Nathaniel Brown | Executive Officer | San Francisco, CA |
| Richard Colonno | Executive Officer | San Francisco, CA |
| Leping Li | Executive Officer | Shanghai, F4 |
| Leo Redmond | Executive Officer | San Francisco, CA |
| Eric Ruby | Executive Officer | San Francisco, CA |
| Pamela Vig | Executive Officer | San Francisco, CA |
| Felix Baker | Director | New York, NY |
| Srinivas Akkaraju | Director | Palo Alto, CA |
| David Jobes | Executive Officer | Doylestown, PA |
| Kenneth Galbraith | Director | Vancouver, A1 |
| Kenneth Galbraith | Executive Officer | Vancouver, A1 |
| Daniel Perez | Director | San Francisco, CA |
| Rodney Ferguson | Director | Menlo Park, CA |
| H. Daniel Perez | Executive Officer | San Francisco, CA |
| Omar Haffar | Executive Officer | San Francisco, CA |
| Richard F Colonno | Executive Officer | San Francisco, CA |
| Scott F Lessing | Director | San Francisco, CA |
| John F Obijeski | Director | San Francisco, CA |
| Leping F Li | Executive Officer | San Francisco, CA |
| Nathaniel F Brown | Executive Officer | San Francisco, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2013-04-17 | D | $15.0M | $8.6M |
| 2012-11-02 | D/A | $14.4M | $14.4M |
| 2011-12-20 | D | $13.0M | $6.0M |
| 2011-08-05 | D | $3.0M | $3.0M |
| 2009-07-10 | D | $33.8M | $18.8M |
| 2009-07-10 | D/A | $33.8M | $18.8M |